Reversal of CD8 T-Cell–Mediated Mucocutaneous Graft-Versus-Host-Like Disease by the JAK Inhibitor Tofacitinib

por Okiyama, Naoko, Furumoto, Yasuko, Villarroel, Vadim A, Linton, Jay T, Tsai, Wanxia L, Gutermuth, Jan, Ghoreschi, Kamran, Gadina, Massimo, O'Shea, John J, Katz, Stephen I
Publicado 2014